African American Cancer Clinical Trial Decisions: Testing Tailored Messages

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

May 1, 2015

Primary Completion Date

March 6, 2020

Study Completion Date

March 6, 2020

Conditions
MyelomaLymphomaLeukemia
Interventions
BEHAVIORAL

EMR Tailoring

Electronic Medical Records (EMR) data alone will be entered into the Michigan Tailoring System (MTS system) and their brochures will be prepared.

BEHAVIORAL

Survey Tailoring

Survey that will use standardized, psycho-metrically sound measures to gather information about patients, including their levels of trust in medical research and preferences for information and decision involvement. The survey augmented by their EMR data will be used to develop a level of tailored messages.

BEHAVIORAL

Physician Involvement

Prior to the consultation, physicians of patients will receive a summary of patients' tailored message brochure from the Research Assistant (RA) and included in the patient's notes. At the conclusion of the consultation, the RA will ask the oncologist whether or not a clinical trial was discussed and whether or not they read the patients brochure.

Trial Locations (1)

23298

Virginia Commonwealth University/Massey Cancer Center, Richmond

All Listed Sponsors
collaborator

American Cancer Society, Inc.

OTHER

lead

Virginia Commonwealth University

OTHER

NCT02356549 - African American Cancer Clinical Trial Decisions: Testing Tailored Messages | Biotech Hunter | Biotech Hunter